Unlike traditional pathology labs, which can only analyse two proteins at a time, this cutting-edge tool can analyse up to 100 proteins and 18,000 genes, providing an unprecedented level of insight into the neural tissue affected by COVID-19. The study aims to identify which cells are damaged and which pathways are activated or deactivated, shedding light on the neurological effects of the virus.
This world-first study will provide an in-depth profile of COVID-19 neural tissues, offering valuable data on neural cell types and gene expression. Moreover, the project will provide an open-source data-sharing tool, enabling researchers worldwide to use the molecular reference tool to understand the neurological effects of COVID-19.
The collaboration has the potential to transform medical research, paving the way for more effective treatments for COVID-19 and other diseases affecting the neural tissue.